Navidea Biopharmaceuticals Inc.
www.navidea.com
Latest From Navidea Biopharmaceuticals Inc.
Earnings Winners & Losers: The Large Diversified Firms, ABT, BAX, CAH, JNJ
Most of the large, diversified medtech companies have now reported their sales and earnings for the second quarter and first half of 2017. All of the companies in this category reported revenue growth and promised investment in new technologies across all their businesses, but a Baxter and Cardinal Health stand out as having especially successful quarters. Abbott is still trying to overcome major challenges, and J&J is turning around its medical device businesses under new leadership.
Norgine Builds Specialty Business In Europe From Canada's Merus Labs
Merus Labs' portfolio of well-established products are mainly marketed in Europe, and will drive the growth and diversification of Norgine’s specialty business in the region.
Execs On The Move, November 2016
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Deals Shaping the Medical Industry, October 2016
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in September 2016.
Company Information
- Industry
- Biotechnology
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- Molecular Imaging
-
Diagnostic Imaging Equipment & Supplies
-
Pharmaceuticals
- Radiopharmaceuticals, Contrast Agents
- Therapeutic Areas
- Cancer
- Neurology, Nervous System
- Alias(es)
- Neoprobe Corp.
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Navidea Biopharmaceuticals Inc.
- Senior Management
-
Jed A Latkin, CFO, COO & Interim CEO
Frederick Cope, PhD, SVP, CSO
William Regan, SVP, Global Reg. & Quality, CCO - Contact Info
-
Navidea Biopharmaceuticals Inc.
Phone: (614) 793-7500
5600 Blazer Pkwy.
Ste. 200
Dublin, OH 43017-1367
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice